Ibubel (Ibuprofen)

Ibuprofen works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2. This inhibition blocks the synthesis of prostaglandins, which are mediators of pain, fever, and inflammation, thereby reducing these symptoms throughout the body.

The appropriate dose of Ibubel is determined by a qualified prescriber based on the patient’s age, weight, clinical condition and response to therapy. Healthcare professionals follow local guidelines and product labeling to select the correct strength and frequency for each individual.

Ibuprofen should be used with caution during pregnancy, especially in the third trimester, because it may affect fetal cardiovascular development. While limited data exist for breastfeeding, ibuprofen does pass into breast milk in small amounts. Consultation with a healthcare provider is essential before use.

To place an order, submit an enquiry on the Ibubel product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibubel delivers ibuprofen systemically via the rectal route, offering an alternative when oral intake is impossible or poorly tolerated. Compared with oral ibuprofen, the suppository may provide faster absorption and fewer gastrointestinal side effects, but the overall efficacy and safety profile remain consistent with other ibuprofen products.

Store Ibubel at room temperature, ideally below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity, which could affect its stability.

Ibubel is inserted rectally, typically with gloved fingers, after the patient has emptied the bowels if possible. The suppository should be placed gently into the rectum, lying on the side, and left in place to dissolve completely for optimal absorption.

Serious risks include gastrointestinal bleeding or ulcer perforation, acute kidney injury, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, and liver toxicity. Patients should seek immediate medical attention if they experience signs of bleeding, sudden kidney problems, or severe skin reactions.

Ibubel should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, severe renal or hepatic impairment, and in late‑stage pregnancy without medical advice. Consultation with a healthcare professional is required for all contraindications.